S

Soleno Therapeutics
D

SLNO

52.770
USD
0.01
(0.02%)
مغلق
حجم التداول
53,192
الربح لكل سهم
4
العائد الربحي
-
P/E
135
حجم السوق
2,729,166,723
أصول ذات صلة المقالات
المزيد

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.